Dual mycobacterial infection in the setting of leflunomide treatment for rheumatoid arthritis [6]

Annals of the Rheumatic Diseases

Volumn 66, Issue 2, 2007, Pages 277-

  Agrawal, S ^a   Sharma, A ^a  

^a HIMALAYAN INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

LEFLUNOMIDE; PREDNISOLONE; TUBERCULOSTATIC AGENT;

ADULT; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DISEASE COURSE; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; LETTER; LEUKOCYTE COUNT; LOW DRUG DOSE; MYCOBACTERIOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN BIOPSY; TREATMENT RESPONSE;

ADULT; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MYCOBACTERIUM LEPRAE; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS;

EID: 33846866540     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.056283     Document Type: Letter

References (6)

1. Hocevar A, Rozman B, Praportnik S, Lestan B, Erzen D, Petric V, et al. Leflunomide-associated tuberculosis? Rheumatology (Oxford) 2000;45:228-9.
2. Carmona L, Hernandez-Gracia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, et al. Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 2003;30:1436-9.
3. Lee HN, Embi CS, Vigeland KM, White CR Jr. Concomitant pulmonary tuberculosis and leprosy. J Am Acad Dermatol 2003;49:755-7.
4. Srilakshmi MA, Amit H, Jayantilal, Raveendraneth S, Pais N. Concomitant infection with pulmonary tuberculosis and lepromatous leprosy. J Assoc Physicians India 2003;51:528-9.
5. Manna SK, Mukhopadhyay A, Aggarwal BB. Leflunomide suppresses TNF-induced cellular responses: effects on NK-kB, activator protein-1, c-jun N-terminal protein kinase and apoptosis. J Immunol 2000;165:5962- 9.
6. Bieber J, Kavanaugh A. Consideration of the risk and treatment of tuberculosis in patients who have rheumatoid arthritis and receive biologic treatment. Rheum Dis Clin North Am 2004;30:257-70.